Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice

Cited by (214)

Items 101–200 of 214

1. Alzheimer’s disease is an inherent, natural part of human brain aging: an integrated perspective
   Isidró Ferrer · 2022 · Free Neuropathology
2. Retromer dysfunction at the nexus of tauopathies
   Carosi, Julian M., Denton, Donna, Kumar, Sharad, Sargeant, Timothy J. · 2021 · Cell Death & Differentiation
3. The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates
   Andreia Ferreira, Ines E. Royaux, Jian Liu, Zhangjie Wang, Guowei Su, Diederik Moechars, Nico Callewaert, Louis De Muynck · 2022 · BMC Molecular and Cell Biology
4. Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases
   Anna Villar‐Piqué, Matthias Schmitz, Niccolò Candelise, Salvador Ventura, Franc Llorens, Inga Zerr · 2018 · Molecular Neurobiology
5. Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody
   Kristof Van Kolen, T. Malia, Clara Theunis, Rupesh K. Nanjunda, A. Teplyakov, Robin Ernst, Sheng‐Jiun Wu, Jinquan Luo, Marianne Borgers, Marc Vandermeeren et al. · 2020 · Journal of Alzheimer s Disease
6. New progress on the role and mechanism of tau protein in Alzheimer's disease and depression
   Yamei Wang, Jing Zhou, Qingqing Zhou, Hua Wang · 2025 · Frontiers in Neurology
7. Nasal Rifampicin Halts the Progression of Tauopathy by Inhibiting Tau Oligomer Propagation in Alzheimer Brain Extract-Injected Mice
   Tomohiro Umeda, Rumi Uekado, Keiko Shigemori, Hiroshi Eguchi, Takami Tomiyama · 2022 · Biomedicines
8. Tau–FG-nucleoporin98 interaction and impaired nucleocytoplasmic transport in Alzheimer’s disease
   Niharika Nag, Timir Tripathi · 2022 · Briefings in Functional Genomics
9. Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation
   Longfei Li, Jin Miao, Dandan Chu, Nana Jin, Yunn Chyn Tung, Chun‐Ling Dai, Wen Hui Hu, Cheng‐Xin Gong, Khalid Iqbal, Fei Liu · 2022 · CNS Neuroscience & Therapeutics
10. A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
    Kevin Llewelyn Batenburg, Claudia Sestito, Paulien Cornelissen‐Steijger, Jan R.T. van Weering, Leo Price, Vivi Majella Heine, Wiep Scheper · 2023 · Biological Procedures Online
11. Secretion of full-length Tau or Tau fragments in cell culture models. Propagation of Tau in vivo and in vitro
    Mar Pérez, Miguel Medina, Félix Hernández, Jesús Ávila · 2018 · BioMolecular Concepts
12. Self‐Aggregating Tau Fragments Recapitulate Pathologic Phenotypes and Neurotoxicity of Alzheimer's Disease in Mice
    Ly Thi Huong Luu Le, Jeeyoung Lee, Dongjoon Im, Sun-Ha Park, Kyoung‐Doo Hwang, Jung Hoon Lee, Yanxialei Jiang, Yong‐Seok Lee, Young Ho Suh, Hugh I. Kim et al. · 2023 · Advanced Science
13. Dextran sulphate-induced tau assemblies cause endogenous tau aggregation and propagation in wild-type mice
    Masami Masuda‐Suzukake, Genjiro Suzuki, Masato Hosokawa, Takashi Nonaka, Michel Goedert, Masato Hasegawa · 2020 · Brain Communications
14. Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects
    Helen M Collins, Susan Adele Greenfield · 2024 · International Journal of Molecular Sciences
15. The use of mouse models to study cell-to-cell transmission of pathological tau
    Sneha Narasimhan, Virginia M.‐Y. Lee · 2017 · Methods in cell biology
16. Strategies to dissect microglia-synaptic interactions during aging and in Alzheimer's disease
    Sarah E. Heuer, Erik B. Bloss, Gareth R. Howell · 2024 · Neuropharmacology
17. Spreading of Pathology in Alzheimer’s Disease
    Zhongyue Lv, Chen‐Chen Tan, Jin‐Tai Yu, Lan Tan · 2017 · Neurotoxicity Research
18. Conformation-based assay of tau protein aggregation
    Yann Fichou, Neil A. Eschmann, Timothy J. Keller, Songi Han · 2017 · Methods in cell biology
19. Sowing the Seeds of Discovery: Tau-Propagation Models of Alzheimer’s Disease
    Benjamin J. Bell, Medhinee M. Malvankar, Carolyn Tallon, Barbara Stauch Slusher · 2020 · ACS Chemical Neuroscience
20. Tau mRNA Metabolism in Neurodegenerative Diseases: A Tangle Journey
    Paulo J. da Costa, Malika Hamdane, Luc Buée, Franck Martin · 2022 · Biomedicines
21. Host Tau Genotype Specifically Designs and Regulates Tau Seeding and Spreading and Host Tau Transformation Following Intrahippocampal Injection of Identical Tau AD Inoculum
    Pol Andrés‐Benito, Margarita Carmona, Mónica Jordán, Joaquín Fernández‐Irigoyen, Enrique Santamaría, José Antonio del Rı́o, Isidró Ferrer · 2022 · International Journal of Molecular Sciences
22. Neurofibrillary tangles mediated human neuronal tauopathies: insights from fly models
    Surajit Sarkar · 2018 · Journal of Genetics
23. Capacity for Seeding and Spreading of Argyrophilic Grain Disease in a Wild-Type Murine Model; Comparisons With Primary Age-Related Tauopathy
    Isidró Ferrer, Pol Andrés‐Benito, Julia Sala‐Jarque, Vanessa Gil, José Antonio del Rı́o · 2020 · Frontiers in Molecular Neuroscience
24. Absence of Uptake and Prion-Like Spreading of Alpha-Synuclein and Tau After Intravitreal Injection of Preformed Fibrils
    Lien Veys, Jessie Van houcke, Jeroen Aerts, Sophie Van Pottelberge, Michel Mahieu, Audrey Coens, Ronald Melki, Dieder Moechars, Louis De Muynck, Lies De Groef · 2021 · Frontiers in Aging Neuroscience
25. The unique neuropathological vulnerability of the human brain to aging
    Isidró Ferrer · 2023 · Ageing Research Reviews
26. FGFR3 drives Aβ-induced tau uptake
    Dong Kyu Kim, K. Y. Suh, Junho Park, Sang‐Eun Lee, Jihui Han, Sunghoe Chang, Youngsoo Kim, Inhee Mook‐Jung · 2024 · Experimental & Molecular Medicine
27. Targeted proteolytic products of τ and α-synuclein in neurodegeneration
    Yuxing Xia, Grace M. Lloyd, Benoit I. Giasson · 2021 · Essays in Biochemistry
28. Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives
    Margrethe A. Olesen, Francisca Villavicencio-Tejo, Victor Cuevas-Espinoza, Rodrigo A. Quintanilla · 2024 · Ageing Research Reviews
29. Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model
    Caitlin Davies, Jane Tulloch, Ellie Yip, Lydia Currie, Martí Colom‐Cadena, Susanne Wegmann, Bradley T. Hyman, Lewis Wilkins, Monique Hooley, Makis Tzioras et al. · 2023 · Brain and Neuroscience Advances
30. Spreading of Tau Protein Does Not Depend on Aggregation Propensity
    Sara Rodrigues, Marta Anglada‐Huguet, Katja Hochgräfe, Senthilvelrajan Kaniyappan, Susanne Wegmann, Eva‐Maria Mandelkow · 2023 · Journal of Molecular Neuroscience
31. Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
    Harish Kumar, Jayant B. Udgaonkar · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
32. Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
    Neha Basheer, Luc Buée, Jean‐Pierre Brion, Tomáš Smolek, Muhammad Khalid Muhammadi, Jozef Hritz, Tomáš Hromádka, Ilse Dewachter, Susanne Wegmann, Isabelle Landrieu et al. · 2024 · Acta Neuropathologica Communications
33. Connectivity as a universal predictor of tau progression in atypical Alzheimer’s disease
    Hannah de Bruin, Colin Groot, Henryk Barthel, Gérard N. Bischof, Ganna Blazhenets, Ronald Boellaard, Baayla D.C. Boon, Matthias Brendel, David M. Cash, William Coath et al. · 2025 · Brain
34. Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study
    Simon Loïodice, Wilhelmus H. I. M. Drinkenburg, Abdallah Ahnaou, Andrew P. McCarthy, Geoffrey Viardot, Emilie Cayre, Bertrand Rion, Valérie Bertaina‐Anglade, Marsel Mano, Philippe L’Hostis et al. · 2021 · Translational Psychiatry
35. TNAP upregulation is a critical factor in Tauopathies and its blockade ameliorates neurotoxicity and increases life-expectancy
    Álvaro Sebastián‐Serrano, Jesús Merchán‐Rubira, Caterina Di Lauro, Carolina Bianchi, Lucía Soria-Tobar, Sonoko Narisawa, José Luís Millán, Jesús Ávila, Félix Hernández, Miguel Dı́az-Hernández · 2022 · Neurobiology of Disease
36. Common and Specific Marks of Different Tau Strains Following Intra-Hippocampal Injection of AD, PiD, and GGT Inoculum in hTau Transgenic Mice
    Isidró Ferrer, Pol Andrés‐Benito, Margarita Carmona, José Antonio del Rı́o · 2022 · International Journal of Molecular Sciences
37. Inefficient induction and spread of seeded tau pathology in P301L mouse model of tauopathy suggests inherent physiological barriers to transmission
    Paramita Chakrabarty, Vincent J. Hudson, Amanda N. Sacino, Mieu Brooks, Simon D’Alton, Jada M. Lewis, Todd Eliot Golde, Benoit I. Giasson · 2015 · Acta Neuropathologica
38. Type I Interferon Signaling Drives Microglial Dysfunction and Senescence in Human iPSC Models of Down Syndrome and Alzheimer's Disease
    Mengmeng Jin, Ranjie Xu, Mahabub Maraj Alam, Ziyuan Ma, Sining Zhu, Le Wang, Alessandra Cadete Martini, Matteo Bernabucci, Ping Xie, Kelvin Y. Kwan et al. · 2021 · SSRN Electronic Journal
39. Dynamics of microtubules and their associated proteins
    Eduardo Elias Benarroch · 2016 · Neurology
40. pTau pathology in the retina of TAU58 mice: association with ganglion cell degeneration and implications on seeding and propagation of pTau from human brain lysates
    Grzegorz Walkiewicz, Alicja Ronisz, Simona Ospitalieri, Grigoria Tsaka, Sandra O. Tomé, Rik R. Vandenberghe, Christine A. F. Von Arnim, Frédéric Rousseau, Joost W. H. Schymkowitz, Lies De Groef et al. · 2024 · Acta Neuropathologica Communications
41. Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research
    Emma Szegvari, Sara A. M. Holec, Amanda L. Woerman · 2025 · Journal of Neurochemistry
42. Short-chain polyphosphates induce tau fibrillation and neurotoxicity in human iPSC-derived retinal neurons
    2025
43. The Adult Neurogenesis Theory of Alzheimer’s Disease
    Carlo Abbate · 2023 · Journal of Alzheimer s Disease
44. Spreading of P301S Aggregated Tau Investigated in Organotypic Mouse Brain Slice Cultures
    Dhwani S. Korde, Christian Humpel · 2022 · Biomolecules
45. Learning Deficits Accompanied by Microglial Proliferation After the Long-Term Post-Injection of Alzheimer’s Disease Brain Extract in Mouse Brains
    Tetsuo Hayashi, Shotaro Shimonaka, Montasir Elahi, Shin‐ei Matsumoto, Koichi Ishiguro, Masashi Takanashi, Nobutaka Hattori, Yumiko Motoi · 2021 · Journal of Alzheimer s Disease
46. Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits
    David J. Koss, Lianne Robinson, Anna Mietelska‐Porowska, Anna Gąsiorowska, Kristina Sepčić, Tom Turk, Marcel Jaspars, Grażyna Niewiadomska, Roderick H. Scott, Bettina Platt et al. · 2015 · Cellular and Molecular Life Sciences
47. Investigational therapeutics for the treatment of progressive supranuclear palsy
    David G. Coughlin, Irene Litvan · 2022 · Expert Opinion on Investigational Drugs
48. Anterograde and Retrograde Propagation of Inoculated Human Tau Fibrils and Tau Oligomers in a Non-Transgenic Rat Tauopathy Model
    Lea Langer Horvat, Ena Španić, Mirjana Babić Leko, Klara Zubčić, Luka Horvat, Maja Mustapić, Patrick R. Hof, Goran Šimić · 2023 · Biomedicines
49. μSPIM Toolset: A software platform for selective plane illumination microscopy
    Daniel Saska, Paul Pichler, Chen Qian, Chrysia Pegasiou, Christopher L. Buckley, Leon Lagnado · 2020 · Journal of Neuroscience Methods
50. Remodeling Tau and Prion Proteins Using Nanochaperons
    Sanjib Bhattacharyya, Kyongwan Kim, W. Teizer · 2017 · Advanced Biosystems
51. Notoginsenoside Fe suppresses diet induced obesity and activates paraventricular hypothalamic neurons
    Hongli Li, Yalei Liu, Chuhe Liu, Lingling Luo, Yin Yao, Fei Li, Liufang Yin, Lai Xu, Qingchun Tong, Cheng Huang et al. · 2019 · RSC Advances
52. Misfolded proteins as a therapeutic target in Alzheimer's disease
    S. Imindu Liyanage, Donald Fredric Weaver · 2019 · Advances in protein chemistry and structural biology
53. Aqueous extractable nonfibrillar and sarkosyl extractable fibrillar Alzheimer’s disease tau seeds have distinct properties
    Anastasie Maté de Gérando, Anita Khasnavis, Lindsay A. Welikovitch, Harshil Bhavsar, Calina A. Glynn, Noé Quittot, Romain Perbet, Bradley T. Hyman · 2024 · Acta Neuropathologica Communications
54. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils
    André Filipe Domingos Marreiro, Kristof Van Kolen, Cristiano Sousa, Liesbet Temmerman, Bruno Vasconcelos, Rosa Crespo Rodriguez, Jan R.T. van Weering, Debby Van Dam, Peter Paul De Deyn, Adrian C. Apetri et al. · 2020 · BMC Molecular and Cell Biology
55. Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer’s Disease Brain
    Ruozhen Wu, Jianlan Gu, Dingwei Zhou, Yunn Chyn Tung, Nana Jin, Dandan Chu, Wen Hui Hu, Jerzy Węgiel, Cheng‐Xin Gong, Khalid Iqbal et al. · 2021 · Journal of Alzheimer s Disease
56. Development of P301S tau seeded organotypic hippocampal slice cultures to study potential therapeutics
    James M. McCarthy, Jasmeet K. Virdee, Jessica Brown, Daniel Ursu, Zeshan Ahmed, Annalisa Cavallini, Hugh Norman Nuthall · 2021 · Scientific Reports
57. Network activity changes in the pathophysiology of Alzheimer’s disease: the role of aging and early entorhinal cortex dysfunction
    Sharay E. Setti, Miranda N. Reed · 2021 · Metabolic Brain Disease
58. All-Trans Retinoic Acid-Induced Cell Surface Heat Shock Protein 90 Mediates Tau Protein Internalization and Degradation in Human Microglia
    Ngoc Lan Nguyen, Thi Xoan Hoang, Jae Young Kim · 2024 · Molecular Neurobiology
59. Differences in Tau Seeding in Newborn and Adult Wild-Type Mice
    Isidró Ferrer, Pol Andrés‐Benito, Paula Garcia‐Esparcia, Irene López‐González, Diego Valiente, Mónica Jordán, Margarita Carmona, Julia Sala‐Jarque, Vanessa Gil, José Antonio del Rı́o · 2022 · International Journal of Molecular Sciences
60. Axonal Transport Impairment and its Relationship with Diffusion Tensor Imaging Metrics of a Murine Model of p301L Tau Induced Tauopathy
    Christopher Nishioka, Hsiao‐Fang Liang, Stephen Ong, Shu‐Wei Sun · 2022 · Neuroscience
61. A Trisomy 21-linked Hematopoietic Gene Variant in Microglia Confers Resilience in Human iPSC Models of Alzheimer’s Disease
    Mengmeng Jin, Ziyuan Ma, Rui Dang, Haiwei Zhang, Rachael Kim, Haipeng Xue, Jesse R. Pascual, Steven M. Finkbeiner, Elizabeth Head, Ying Min Liu et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
62. Advancing Alzheimer’s research by improving disease modeling of secondary tauopathy
    Ethan R. Roy, Wei Cao · 2025 · npj Dementia
63. Illuminating the Structural Basis of Tau Aggregation by Intramolecular Distance Tracking: A Perspective on Methods
    Zhikai Zeng, Yann Fichou, Michael P. Vigers, Karen Tsay, Songi Han · 2022 · The Journal of Physical Chemistry B
64. Identifying therapeutic targets and treatments in model systems
    Corinne Ida Lasmézas, Ruth Gabizon · 2018 · Handbook of clinical neurology
65. Editorial: Pathogenic templating proteins in Neurodegenerative Disease
    Laura A. Volpicelli‐Daley, Patrik Brundin · 2017 · Neurobiology of Disease
66. Synergistic associations of amyloid-β and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease
    Chunhua Zhang, Yaojun Tai, Min Kong, Pengyuan Jia, Guozhao Ma, Maowen Ba, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Journal of Alzheimer s Disease
67. In Vitro and In Vivo Evaluation of Small-Molecule Disassemblers of Pathological Tau Fibrils
    Hope Pan, Xinyi Cheng, Jeffrey Zhang, Ke Hou, Kevin A. Murray, Kapil Manglani, Cansheng Zhu, Hung‐Kai Hsu, Marisa Mekkittikul, Tyler Halladay et al. · 2026 · ACS Chemical Neuroscience
68. Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models
    Shireen Salem, Melanie Alpaugh, Martine Saint‐Pierre, Flávia Natale Borba, Catalina Cerquera‐Cleves, Mado Lemieux, Soki Bradel Ngonza-Nito, Paul De Koninck, Ronald Melki, Francesca Cicchetti · 2024 · Neurobiology of Disease
69. Methods to detect AUTOphagy-Targeting Chimera (AUTOTAC)-mediated Targeted Protein Degradation in Tauopathies
    Min Ju Lee, Su Kim, Hee Yeon Kim, Su Jin Lee, Ji Su Lee, Yong Tae Kwon, Chang Hoon Ji · 2023 · BIO-PROTOCOL
70. The effects of social environment on AD-related pathology in hAPP-J20 mice and tau-P301L mice
    Suzanne D. Lanooij, Wilhelmus H. I. M. Drinkenburg, Ulrich L.M. Eisel, Eddy A. van der Zee, Martien J. Kas · 2023 · Neurobiology of Disease
71. Symptomatic and preclinical Alzheimer’s disease: Neuropathology and imaging
    Dietmar Rudolf Thal · 2016 · Neurology Psychiatry and Brain Research
72. Prion-Like Propagation in Neurodegenerative Diseases
    Wouter Peelaerts, Veerle Baekelandt, Patrik Brundin · 2018 · Elsevier eBooks
73. Soluble Brain Homogenates from Diverse Human and Mouse Sources Preferentially Seed Diffuse Aβ Plaque Pathology When Injected into Newborn Mouse Hosts
    Brenda D. Moore, Yona Levites, Guilian M. Xu, Hailey Hampton, Munir F Adamo, Cara L. Croft, Hunter S. Futch, Corey Moran, Susan Fromholt, Christopher Janus et al. · 2021 · Research Square
74. Common Mechanism Underlying Synaptic Dysfunction Caused by Preformed Fibril-Induced Accumulation of α-Synuclein or Tau in a Culture Propagation Model
    Dimitar Dimitrov, Sruthi Raja, Humaira Noor, Tomoyuki Takahashi · 2025 · Journal of Neuroscience
75. A myeloid trisomy 21-associated gene variant is protective from Alzheimer’s disease
    Mengmeng Jin, Ziyuan Ma, Rui Dang, Haiwei Zhang, Rachael Kim, Haipeng Xue, Jesse R. Pascual, Hanwen Yu, Ava V. Papetti, Yàn Liú et al. · 2025 · Nature Neuroscience
76. Cryo-EM structure of pro-aggregant P301L/S320F double-mutant tau filaments formed in mouse brains following peripheral AAV delivery
    Maria Kano, 木村 妙子, Haruaki Yanagisawa, Komei Yamashita, Lisa Tatsumi, Asahi Sakai, Xinyi Li, Takaomi C. Saido, Takashi Saito, Sho Takatori et al. · 2026 · Acta Neuropathologica Communications
77. Tau pathology in epilepsy: emerging mechanisms and translational opportunities
    Arjune Sen, Xin You Tai, Aristea S. Galanopoulou, Maria Thom, Eleonora Aronica, Lucy E. Vivash, Martin Hardmeier, A. Amos, Stephan J. Rüegg, Matthias J. Koepp et al. · 2026 · Brain
78. A Human Neuron/Astrocyte Co‐culture to Model Seeded and Spontaneous Intraneuronal Tau Aggregation
    Kevin Llewelyn Batenburg, Susan Karijn Rohde, Paulien Cornelissen‐Steijger, Nicole Breeuwsma, Vivi Majella Heine, Wiep Scheper · 2023 · Current Protocols
79. GPCR-mediated clearance of tau in post-synaptic compartments attenuates tau pathology in vivo
    Ari W. Schaler, Avery M. Runyan, Stephanie L. Fowler, Helen Y. Figueroa, Seiji Shioda, Ismael Santa‐María, Karen Duff, Natura Myeku · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
80. Neuronal APOE4 alone is sufficient to drive tau pathology, neurodegeneration, and neuroinflammation in an Alzheimer’s disease mouse model
    Jessica R. Blumenfeld, Yaqiao Li, Min Joo Kim, Oscar Yip, Leon Yao, Samuel De Leon, Rebecca Fulthorpe, David M. Shostak, Zoe Platow, Kaylie Suan et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
81. Aβ remotely and locally facilitates Alzheimer’s disease tau spreading
    Fardin Nabizadeh, Alzheimer’s Disease Neuroimaging Initiative, Fardin Nabizadeh · 2024 · Cerebral Cortex
82. Tau Pathology in Alzheimer's Disease: Bridging Molecular Mechanisms and Targeted Therapies
    Mini Dahiya, Monu Yadav, Anil Kumar, Chetan Goyal · 2025 · CNS & Neurological Disorders - Drug Targets
83. Development and Characterization of Mouse-Specific Anti-Tau Monoclonal Antibodies: Relevance for Analysis of Murine Tau in Cerebrospinal Fluid
    Dina Rodrigues Martins, Marc Vandermeeren, Kristof Van Kolen, Eddy Brepoels, Marianne Borgers, Cindy Wintmolders, Charlotte Delay, Astrid Bottelbergs, Marc H. Mercken, Clara Theunis · 2023 · Journal of Alzheimer s Disease
84. Traumatic Brain Injury and Neurodegenerative Disease
    Dawn McGuire · 2018 · Wiley eBooks
85. Type I Interferon Signaling Drives Microglial Dysfunction and Senescence in Human iPSC Models of Down Syndrome and Alzheimer’s Disease
    Mengmeng Jin, Ranjie Xu, Le Wang, Mahabub Maraj Alam, Ziyuan Ma, Sining Zhu, Alessandra Cadete Martini, Azadeh Jadali, Matteo Bernabucci, Ping Xie et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
86. Functional implications of tau-fyn interactions in Alzheimer's disease
    Hay Wun Dawn Lau · 2015
87. Transmission Properties of Pathogenic Protein Agents in Human Prion Disease and Neurodegenerative Diseases
    He Liu · 2016 · International Journal of Cell Science & Molecular Biology
88. Engineering antibody therapeutics and cell culture models for neurodegenerative diseases
    Kyle P. McHugh · 2024 · Library, Museums and Press - UDSpace (University of Delaware)
89. Investigation of the intercellular transmission of α-synuclein, amyloid-β and TDP-43
    Christopher Sackmann · 2019 · Linköping University medical dissertations
90. THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
    Ryan Cloyd · 2021 · UKnowledge (University of Kentucky)
91. Host Tau Genotype Specifically Regulates and Designs Tau Seeding and Spreading Following Intracerebral Injection of Identical Tau ADInoculum
    Pol Andrés‐Benito, Margarita Carmona, Mónica Jordán, José Antonio del Rı́o, Isidró Ferrer · 2021 · Research Square
92. Prion infections and tauopathy in animal models: disease progression and proteolysis
    Ghazaleh Eskandari‐Sedighi · 2020 · ERA: Education and Research Archive (University of Alberta)
93. Host Tau Genotype Specifically Regulates and Designs Tau Seeding and Spreading Following Intracerebral Injection of Identical Tau AD Inoculum
    Pol Andrés‐Benito, Margarita Carmona, Mónica Jordán, José Antonio del Rı́o, Isidró Ferrer · 2021 · Research Square
94. Identification and Analysis of Axolotl Homologs for Proteins Implicated in Human Neurodegenerative Proteinopathies
    Lucas M. James, Zachary Strickland, Noah J. Lopez, Jessica L. Whited, Malcolm Maden, Jada M. Lewis · 2024 · Genes
95. Molecular and Cellular Mechanisms of Primary Tauopathies
    Shiaoching Gong, Li Gan · 2025 · Oxford University Press eBooks
96. Additional file 2 of Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils
    André Filipe Domingos Marreiro, Kristof Van Kolen, Sousa, Cristiano, Temmerman, Liesbet, Bruno Vasconcelos, Rosa Crespo Rodriguez, van Weering, Jan R. T., Debby Van Dam, De Deyn, Peter P., Adrian C. Apetri et al. · 2020 · Figshare
97. Additional file 1 of The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates
    Andreia Ferreira, Ines E. Royaux, Jian Liu, Wang, Zhangjie, Guowei Su, Diederik Moechars, Nico Callewaert, Louis De Muynck · 2024 · Figshare
98. Additional file 1 of A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
    Kevin Llewelyn Batenburg, Claudia Sestito, Paulien Cornelissen‐Steijger, van Weering, Jan R. T., Leo Price, Vivi Majella Heine, Wiep Scheper · 2024 · Figshare
99. Additional file 1 of Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils
    André Filipe Domingos Marreiro, Kristof Van Kolen, Sousa, Cristiano, Liesbet Temmerman, Bruno Vasconcelos, Rosa Crespo Rodriguez, van Weering, Jan R. T., Debby Van Dam, De Deyn, Peter P., Adrian C. Apetri et al. · 2020 · Figshare
100. Additional file 2 of A 3D human co-culture to model neuron-astrocyte interactions in tauopathies
     Kevin Llewelyn Batenburg, Claudia Sestito, Paulien Cornelissen‐Steijger, van Weering, Jan R. T., Leo Price, Vivi Majella Heine, Wiep Scheper · 2024 · Figshare